PEOPLE - Changes at Aksys
This article was originally published in Clinica
Executive Summary
Aksys, the Lincolnshire, Illinois haemodialysis products firm, has announced changes to most of its board, effective June 23. The new directors are: Dr Douglass Given (partner and life sciences advisor/investor at merchant bank Bay City Capital); Timothy Mayleben (life science and healthcare company consultant, and director of NightHawk Radiology Holdings and Aastron Biosciences); Gretchen Piller (director of research for asset management firm Torrey Associates); and Leslie Lake (MD of private equity firm Invus Group).
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.